Büchler MW - Search Results

1

Extended pancreatectomy in pancreatic ductal adenocarcinoma: definition and consensus of the International Study Group for Pancreatic Surgery (ISGPS).

Hartwig W, Vollmer CM, Fingerhut A, Yeo CJ, Neoptolemos JP, Adham M, Andrén-Sandberg A, Asbun HJ, Bassi C, Bockhorn M, Charnley R, Conlon KC, Dervenis C, Fernandez-Cruz L, Friess H, Gouma DJ, Imrie CW, Lillemoe KD, Milićević MN, Montorsi M, Shrikhande SV, Vashist YK, Izbicki JR, Büchler MW; International Study Group on Pancreatic Surgery. Hartwig W, et al. Among authors: buchler mw. Surgery. 2014 Jul;156(1):1-14. doi: 10.1016/j.surg.2014.02.009. Epub 2014 Feb 20. Surgery. 2014. PMID: 24856668

2

Standards in monitoring acute experimental pancreatitis.

Friess H, Weber A, Büchler M. Friess H, et al. Eur Surg Res. 1992;24 Suppl 1:1-13. doi: 10.1159/000129234. Eur Surg Res. 1992. PMID: 1376253 Review.

3

[Somatostatin analogs: a new therapeutic concept in pancreatic cancer?].

Friess H, Kunz J, Büchler M. Friess H, et al. Z Gastroenterol. 1992 Nov;30(11):818-9. Z Gastroenterol. 1992. PMID: 1471391 German. No abstract available.

4

Treatment of duct carcinoma of the pancreas with the LH-RH analogue buserelin.

Friess H, Büchler M, Krüger M, Beger HG. Friess H, et al. Pancreas. 1992;7(5):516-21. doi: 10.1097/00006676-199209000-00002. Pancreas. 1992. PMID: 1513800

5

[Nerve sheath infiltration in pancreas carcinoma: clinical consequences].

Friess H, Büchler M. Friess H, et al. Z Gastroenterol. 1992 Feb;30(2):163-4. Z Gastroenterol. 1992. PMID: 1553835 German. No abstract available.

6

A randomized controlled trial of adjuvant immunotherapy (murine monoclonal antibody 494/32) in resectable pancreatic cancer.

Büchler M, Friess H, Schultheiss KH, Gebhardt C, Kübel R, Muhrer KH, Winkelmann M, Wagener T, Klapdor R, Kaul M, et al. Büchler M, et al. Cancer. 1991 Oct 1;68(7):1507-12. doi: 10.1002/1097-0142(19911001)68:7<1507::aid-cncr2820680707>3.0.co;2-0. Cancer. 1991. PMID: 1654194 Clinical Trial.

7

LH-RH receptors in the human pancreas. Basis for antihormonal treatment in ductal carcinoma of the pancreas.

Friess H, Büchler M, Kiesel L, Krüger M, Beger HG. Friess H, et al. Int J Pancreatol. 1991 Oct;10(2):151-9. Int J Pancreatol. 1991. PMID: 1660910

8

Role of octreotide in the prevention of postoperative complications following pancreatic resection.

Büchler M, Friess H, Klempa I, Hermanek P, Sulkowski U, Becker H, Schafmayer A, Baca I, Lorenz D, Meister R, et al. Büchler M, et al. Am J Surg. 1992 Jan;163(1):125-30; discussion 130-1. doi: 10.1016/0002-9610(92)90264-r. Am J Surg. 1992. PMID: 1733360 Clinical Trial.

9

Studies of pancreatic cancer utilizing monoclonal antibodies.

Büchler M, Friess H, Malfertheiner P, Schultheiss KH, Muhrer KH, Kraemer HP, Beger HG. Büchler M, et al. Int J Pancreatol. 1990 Aug-Nov;7(1-3):151-7. doi: 10.1007/BF02924232. Int J Pancreatol. 1990. PMID: 1964470 Clinical Trial.

10

[Possibilities of application of octreotide in surgery. 1)Treatment of gastrointestinal fistulas; 2)Prevention of complications in pancreatic surgery].

Büchler M, Friess H, Beger HG. Büchler M, et al. Z Gastroenterol. 1990 Sep;28 Suppl 2:41-4. Z Gastroenterol. 1990. PMID: 1980777 Review. German. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,809 results

Search Page